Latest News

STAT Plus: Pharmalittle: Biologic makers use scare tactics to ward off biosimilar use; insulin prices are raised

Good morning, everyone, and nice to see you again after a few days of running around the equivalent of Woodstock for ravenous biopharma executives and investors. Now, though, the spectacle is winding down and we are returning to something resembling our usual routine, although we confess that we will take a break tomorrow, so a colleague will fill in during our absence. Meanwhile, here are some tidbits to help you focus on your own journey. Hope all goes well and do drop us a line if something interesting, unusual or scandalous occurs …

U.S. government officials are growing concerned that biologic makers are using scare tactics to ward off biosimilar versions of their products, The Washington Post reports. “I am worried that there are either deliberate or unintentional efforts by branded companies to create confusion,” says Food and Drug Administration Commissioner Scott Gottlieb. The campaign of confusing, mixed messages has been underway for years but is attracting greater attention as market competition edges closer to reality.

Continue to STAT Plus to read the full story…

Source link

Related posts

Threat of Ebola in Ireland remains very low, the European Centre for Disease Prevention and Control declares


Medical News Today: What does a healthy open relationship look like?


Medical News Today: Cervical effacement and how to measure it


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy